FreeMD® Waldenstrom's Macroglobulinemia Outlook

Waldenstrom's Macroglobulinemia

Outlook

Waldenstrom's Macroglobulinemia Outlook

What to expect with Waldenstrom's macroglobulinemia:

With treatment, most patients survive for more than 5 years.

Continue to Waldenstrom's Macroglobulinemia Complications

View more Red blood cells and anemia topics

Related Conditions

Lymphoma
Multiple myeloma

Easy bleeding
Easy bruising
Loss of appetite
Weakness or fatigue
Weight loss

freeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.

Last Updated: Apr 7, 2008 References

Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD

Site Map

Waldenstrom's Macroglobulinemia References:

Bjorkholm M, Johansson E, Papamichael D, Celsing F, Matthews J, Lister TA, Rohatiner AZ. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study. Semin Oncol. 2003 Apr;30(2):226-30.
Chen CI. Treatment for Waldenstrom's macroglobulinemia. Ann Oncol. 2004 Apr;15(4):550-8.
Dimopoulos MA, Anagnostopoulos A. Waldenstrom's macroglobulinemia. Best Pract Res Clin Haematol. 2005;18(4):747-65.
Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenstrom's macroglobulinemia. J Clin Oncol. 2005 Mar 1;23(7):1564-77.